Acurx Pharmaceuticals Inc
ACXP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.78M
Close$
$4.35
306.8% upside
Current Fair Value
306.8% upsideUndervalued by 306.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.78 Million |
|---|---|
| Enterprise Value | $-4,874,606.00 |
| Earnings per Share | $-5.32 |
| Beta | -2.05 |
| Outstanding Shares | 4,259,540 |
Return
| Return on Equity | -122139.81% |
|---|---|
| Return on Assets | -90642.49% |
| Return on Invested Capital | -24416.02% |
Valuation & Multiples
| P/E Ratio | -0.29 |
|---|---|
| PEG | 0.29 |
| Price to Sales | - |
| Price to Book Ratio | 1.07 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.38
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.45
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.36%▼ 2.56% |
|---|---|
| Total Invested | $19,158▼ 90.06% |
| Investors Holding | 2▼ 17.00% |
About Acurx Pharmaceuticals Inc
3 employees
